Stocks That Hit 52-Week Lows On Friday
Before 10 a.m. ET on Friday, 43 companies set new 52-week lows.
58 Biggest Movers From Yesterday
Gainers
The Glimpse Group, Inc. (NASDAQ: VRAR) shares jumped 152.3% to settle at $17.66 on Thursday after the company priced its IPO at $7 per share.
Alzamend Neuro Submits IND Application For Alzheimer’s-Related Dementia Candidate
Ault Global Holdings Inc (NYSE:DPW), a diversified holding company, has announced that Alzamend Neuro Inc (NASDAQ:ALZN) has submitted an investigational new drug…
Ault Global Holdings Announces That Alzamend Neuro Has Submitted an IND Application for AL001 for Dementia Related to Alzheimer’s Disease
Ault Global Holdings, Inc. (NYSE:DPW) a diversified holding company (the "Company"), announced today that Alzamend Neuro, Inc. (NASDAQ:ALZN) ("Alzamend"), a preclinical stage
72 Biggest Movers From Yesterday
Gainers
Pop Culture Group Co., Ltd (NASDAQ: CPOP) shares jumped 405% to close at $30.30 on Wednesday after the company priced its IPO at $6 per share.
Alzamend Neuro Shares Spike Higher; Traders Circulate Florida Daily Report ‘Ron DeSantis: Florida Increasing Funds to Help Those With Alzheimer’s, Dementia;’ BZ NOTE: Co Based In Tampa, Florida
https://www.floridadaily.com/ron-desantis-florida-increasing-funds-to-help-those-with-alzheimers-dementia/
The Daily Biotech Pulse: Gemini Sinks On Data, Amgen’s Migraine Drug Approved In Japan, Liver Congress Gets Underway
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 22)
26 Stocks Moving in Wednesday’s Pre-Market Session
Gainers
Acasti Pharma Inc. (NASDAQ: ACST) rose 39% to $0.75 in pre-market trading after jumping 10% on Tuesday. The company reported a narrower FY21 loss.
The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy’s Launches Generic Vascepa, Halozyme Strikes Licensing Deal
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 21)